366
Views
10
CrossRef citations to date
0
Altmetric
Review Articles

Phosgene oxime: a highly toxic urticant and emerging chemical threat

, , &
Pages 288-292 | Received 26 Oct 2020, Accepted 05 Dec 2020, Published online: 22 Dec 2020

References

  • Armstrong JR, Bishop.  2002. Chemical warfare: a terrorist attack using chemical weapons can be just as devastating as bioterrorism. A military nurse shares key facts that can help you care for the victims safely and efficiently. (A Readied Response). [updated 2002 April; accessed 65 4].
  • Augerson W. 2000. A review of the scientific literature as it pertains to gulf war illnesses: volume 5: chemical and biological warfare agents. Santa Monica (CA): RAND Corporation.
  • Balali-Mood M, Afshari R, Zojaji R, Kahrom H, Kamrani M, Attaran D, Mousavi SR, Zare GA. 2005. Delayed toxic effects of sulfur mustard on respiratory tract of Iranian veterans. (1477-0903 (Electronic)). eng.
  • CDC 2011. Phosgene Oxime (CX): Blister Agent. National Institute for Occupational Safety and Health (NIOSH); [updated 2011 May 12]. https://www.cdc.gov/niosh/ershdb/emergencyresponsecard_29750009.html.
  • Chang TW, Chen C, Lin CJ, Metz M, Church MK, Maurer M. 2015. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria. J Allergy Clin Immunol. 135(2):337–342. eng.
  • Chulov M. 2017. Sarin used in April Syria attack, chemical weapons watchdog confirms. The Guardian.
  • Dacre JC, Goldman M. 1996. Toxicology and pharmacology of the chemical warfare agent sulfur mustard. Pharmacol Rev. 48(2):289–326.
  • Dang C, Kare J, Shneiderman A, Dang ABC. 2002. Chemical warfare agents. Adv Emerg Nurs J. 24(2):25–39.
  • Dickinson ET, Love JS. 2017. A review of chemical warfare agents and treatment options. J Emerg Med Serv. 42(9).
  • Ganesan K, Raza SK, Vijayaraghavan R. 2010. Chemical warfare agents. J Pharm Bioallied Sci. 2(3):166–178.
  • Geraci MJ. 2008. Mustard gas: imminent danger or eminent threat? (1542-6270 (Electronic)). eng.
  • Ghabili K, Agutter PS, Ghanei M, Ansarin K, Shoja MM. 2010. Mustard gas toxicity: the acute and chronic pathological effects. J Appl Toxicol. 30(7):627–643.
  • Ghasemi H, Owlia P, Jalali-Nadoushan MR, Pourfarzam S, Azimi G, Yarmohammadi ME, Shams J, Fallahi F, Moaiedmohseni S, Moin A, et al. 2013. A clinicopathological approach to sulfur mustard-induced organ complications: a major review. Cutan Ocul Toxicol. 32(4):304–324. eng.
  • Gordon MKE, Robert W, Babin MC. 2009. Ocular toxicity of sulfur mustard. In Gupta RC, editor. Handbook of toxicology of chemical warfare agents. Oxford, UK: Elsevier Inc.; p. 575–594.
  • Goswami DG, Agarwal R, Tewari-Singh N. 2018. Phosgene oxime: Injury and associated mechanisms compared to vesicating agents sulfur mustard and lewisite. Toxicol Lett. 293:112–119.
  • Goswami DG, Kumar D, Tewari-Singh N, Orlicky DJ, Jain AK, Kant R, Rancourt RC, Dhar D, Inturi S, Agarwal C, et al. 2015. Topical nitrogen mustard exposure causes systemic toxic effects in mice. Exp Toxicol Pathol. 67(2):161–170. eng.
  • Goswami DG, Tewari-Singh N, Agarwal R. 2016. Corneal toxicity induced by vesicating agents and effective treatment options. Ann N Y Acad Sci. 1374(1):193–201. eng.
  • Goswami DG, Tewari-Singh N, Dhar D, Kumar D, Agarwal C, Ammar DA, Kant R, Enzenauer RW, Petrash JM, Agarwal R. 2016. Nitrogen mustard-induced corneal injury involves DNA damage and pathways related to inflammation, epithelial-stromal separation, and neovascularization. Cornea. 35(2):257–266. eng.
  • Hennino A, Bérard F, Guillot I, Saad N, Rozières A, Nicolas J-F. 2006. Pathophysiology of urticaria. Clin Rev Allergy Immunol. 30(1):3–11.
  • Inturi S, Tewari-Singh N, Agarwal C, White CW, Agarwal R. 2014. Activation of DNA damage repair pathways in response to nitrogen mustard-induced DNA damage and toxicity in skin keratinocytes. Mutat Res. 763–764:53–63.
  • Jain S. 2014. Pathogenesis of chronic urticaria: an overview. Dermatol Res Pract. 2014:674709.
  • Jain AK, Tewari-Singh N, Gu M, Inturi S, White CW, Agarwal R. 2011. Sulfur mustard analog, 2-chloroethyl ethyl sulfide-induced skin injury involves DNA damage and induction of inflammatory mediators, in part via oxidative stress, in SKH-1 hairless mouse skin. Toxicol Lett. 205(3):293–301.
  • Jain AK, Tewari-Singh N, Inturi S, Orlicky DJ, White CW, Agarwal R. 2014. Myeloperoxidase deficiency attenuates nitrogen mustard-induced skin injuries. Toxicology. 320:25–33.
  • Joseph LB, Gerecke DR, Heck DE, Black AT, Sinko PJ, Cervelli JA, Casillas RP, Babin MC, Laskin DL, Laskin JD. 2011. Structural changes in the skin of hairless mice following exposure to sulfur mustard correlate with inflammation and DNA damage. Exp Mol Pathol. 91(2):515–527.
  • Jowsey PA, Williams FM, Blain PG. 2009. DNA damage, signalling and repair after exposure of cells to the sulphur mustard analogue 2-chloroethyl ethyl sulphide. Toxicology. 257(3):105–112.
  • Kadar T, Cohen M, Cohen L, Fishbine E, Sahar R, Brandeis R, Dachir S, Amir A. 2013. Endothelial cell damage following sulfur mustard exposure in rabbits and its association with the delayed-onset ocular lesions. Cutan Ocul Toxicol. 32(2):115–123. eng.
  • Kadar T, Dachir S, Cohen M, Gutman H, Cohen L, Brandeis R, Horwitz V, Amir A. 2013. Prolonged impairment of corneal innervation after exposure to sulfur mustard and its relation to the development of delayed limbal stem cell deficiency. Cornea. 32(4):e44–e50.
  • Kadar T, Dachir S, Cohen L, Sahar R, Fishbine E, Cohen M, Turetz J, Gutman H, Buch H, Brandeis R, et al. 2009. Ocular injuries following sulfur mustard exposure-pathological mechanism and potential therapy. Toxicology. 263(1):59–69. eng.
  • Kehe K, Balszuweit F, Emmler J, Kreppel H, Jochum M, Thiermann H. 2008. Sulfur mustard research–strategies for the development of improved medical therapy. Eplasty. 8:e32:312–332. eng.
  • Kehe K, Szinicz L. 2005. Medical aspects of sulphur mustard poisoning. Toxicology. 214(3):198–209.
  • Kohnavard N. 2016. Iraqi town Taza ’hit in IS chemical attack’ appeals for help. Taza, Northern Iraq: BBC World News: BBC BBC Persian.
  • McAdams A, Joffe MH. 1965. A toxico-pathologic study of phosgene oxime. Army Chemical Center (MD): Medical Laboratories.
  • McNutt P, Hamilton T, Nelson M, Adkins A, Swartz A, Lawrence R, Milhorn D. 2012. Pathogenesis of acute and delayed corneal lesions after ocular exposure to sulfur mustard vapor. Cornea. 31(3):280–290.
  • Nebehay S. 2017. Syrian government forces used chemical weapons more than two dozen times: U.N. Reuters.
  • Paromov V, Suntres Z, Smith M, Stone WL. 2007. Sulfur mustard toxicity following dermal exposure: role of oxidative stress, and antioxidant therapy. J Burns Wounds. 7:e7. eng.
  • Patočka J, Kuča K. 2011. Phosgene oxime-forgotten chemical weapon. MMSL. 80(1):38–41.
  • Rosenbloom M, Leikin JB, Vogel SN, Chaudry ZA. 2002. Biological and chemical agents: a brief synopsis. Am J Ther. 9(1):5–14. eng.
  • Saladi RN, Smith E, Persaud AN. 2006. Mustard: a potential agent of chemical warfare and terrorism. Clin Exp Dermatol. 31(1):1–5.
  • SAMSFoundation. 2015. SAMS hospital sees mustard gas victims in Mare’e, Aleppo. https://www.sams-usa.net/press_release/press-release-sams-hospital-sees-mustard-gas/.
  • Schraga ED, Dembek ZF. 2016. Phosgene oxime exposure. Medscape; [accessed 2020].
  • Shakarjian MP, Heck DE, Gray JP, Sinko PJ, Gordon MK, Casillas RP, Heindel ND, Gerecke DR, Laskin DL, Laskin JD. 2010. Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure. Toxicol Sci. 114(1):5–19.
  • Sharma M, Pant SC, Pant JC, Vijayaraghavan R. 2010. Nitrogen and sulphur mustard induced histopathological observations in mouse visceral organs. J Environ Biol. 31(6):891–905. eng.
  • Tewari-Singh N. 2020. Phosgene oxime. In: Gupta RC, editor. Handbook of toxicology of chemical warfare agents. 3rd ed. San Diego (CA): Elsevier Inc./Academic Press; p. 197–201.
  • Tewari-Singh N, Agarwal R. 2016. Mustard vesicating agent-induced toxicity in the skin tissue and silibinin as a potential countermeasure. Ann N Y Acad Sci. 1374(1):184–192. eng.
  • Tewari-Singh N, Croutch CR, Tuttle R, Goswami DG, Kant R, Peters E, Culley T, Ammar DA, Enzenauer RW, Petrash JM, et al. 2016. Clinical progression of ocular injury following arsenical vesicant lewisite exposure. Cutan Ocul Toxicol. 35(4):319–328.
  • Tewari-Singh N, Goswami DG, Kant R, Croutch CR, Casillas RP, Orlicky DJ, Agarwal R. 2017. Cutaneous exposure to vesicant phosgene oxime: acute effects on the skin and systemic toxicity. Toxicol Appl Pharmacol. 317:25–32.
  • Tewari-Singh N, Rana S, Gu M, Pal A, Orlicky DJ, White CW, Agarwal R. 2009. Inflammatory biomarkers of sulfur mustard analog 2-chloroethyl ethyl sulfide-induced skin injury in SKH-1 hairless mice. Toxicol Sci. 108(1):194–206.
  • Ubels JL, Edelhauser HF, Austin KH. 1982. A comparison of healing of corneal epithelial wounds stained with fluorescein or Richardson’s stain. Invest Ophthalmol Vis Sci. 23(1):127–131. eng.
  • USACHPPM. 1998. Detailed facts about blister agent phosgene oxime (CX). Aberdeen Proving Ground (MD): US Army Center for Health Promotion and Preventive Medicine.
  • Watson AP, Griffin GD. 1992. Toxicity of vesicant agents scheduled for destruction by the Chemical Stockpile Disposal Program. Environ Health Perspect. 98:259–280.
  • Wormser U, Brodsky B, Proscura E, Foley JF, Jones T, Nyska A. 2005. Involvement of tumor necrosis factor-alpha in sulfurmustard-induced skin lesion; effect of topical iodine. Arch. Toxicol. 79:660–670.
  • Young R, Bast C. 2009. Chapter 8, mustards and vesicants. In: Gupta RC, editor. Handbook of toxicology of chemical warfare agents. Academic Press; p. 93–108.
  • Zajtchuk R, Bellamy RF. 1997. Chapter phosgene oxime, part I: medical aspects of chemical and biological warfare. In: Textbook of military medicine. Washington (DC): Department of the Army, Office of The Surgeon General, Borden Institute; p. 220–222.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.